← back to search

Mei Dong

Gilead Sciences (United States) · US
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Respiratory viral infections research, Lymphoma Diagnosis and Treatment, SARS-CoV-2 and COVID-19 Research, and Acute Myeloid Leukemia Research.
h-index
15
citations
636
works
74
NIH funding
primary concept
email

Recent publications

Magrolimab plus azacitidine vs physician’s choice for untreated <i>TP53</i>-mutated acute myeloid leukemia: the ENHANCE-2 study
Blood 2025cited by 47position: middledoi
Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Acute Myeloid Leukaemia
eJHaem 2025cited by 2position: middledoi
Changes in the BTK/NF-κB signaling pathway and related cytokines in different stages of neuromyelitis optica spectrum disorders
European journal of medical research 2022cited by 11position: lastdoi
Identification of blood-derived candidate gene markers and a new 7-gene diagnostic model for multiple sclerosis
Biological Research 2021cited by 28position: lastdoi
Salidroside suppresses nonsmall cell lung cancer cells proliferation and migration via microRNA-103-3p/Mzb1
Anti-Cancer Drugs 2020cited by 33position: lastdoi
Prostatic adenocarcinoma presenting with metastases to the testis and epididymis: A case report
Oncology Letters 2015cited by 15position: middledoi
Voltage-gated sodium channels were differentially expressed in human normal prostate, benign prostatic hyperplasia and prostate cancer cells
Oncology Letters 2014cited by 31position: middledoi
Internal carotid cavernous fistula: One case report and literature review
Journal of Translational Internal Medicine 2014cited by 1position: middledoi
RNA interference-mediated silencing of VEGF and bFGF suppresses endostatin secretion in pancreatic carcinoma cells
Oncology Letters 2013cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Taravat Bagheri · Gilead Sciences (United States)2 papers (2025–2025)Naval Daver · The University of Texas MD Anderson Cancer Center2 papers (2025–2025)Tianyi Zhao · GenVec2 papers (2021–2022)Huimin Qiao · Hebei Medical University2 papers (2021–2022)Haolong Fan · Hebei Medical University2 papers (2021–2022)Zhuofeng Mao · Hebei Medical University2 papers (2014–2022)Huiqing Hou · Hebei Medical University2 papers (2021–2022)Paresh Vyas · John Radcliffe Hospital2 papers (2025–2025)Chuan Wang · Hebei Medical University2 papers (2013–2015)Changqing Yan · Shandong University of Science and Technology2 papers (2013–2014)Guru Subramanian Guru Murthy · Medical College of Wisconsin1 papers (2025–2025)Pau Montesinos · Hospital Universitari i Politècnic La Fe1 papers (2025–2025)Yan-Fen Guo · Hebei Medical University1 papers (2014–2014)Parul Doshi · Bristol-Myers Squibb (United States)1 papers (2025–2025)Christian Récher · Centre National de la Recherche Scientifique1 papers (2025–2025)George Yaghmour · Case Western Reserve University1 papers (2025–2025)Anoop Enjeti · Australian National University1 papers (2025–2025) · 1 papers (2025–2025)Xiaocui Jiao · Capital Medical University1 papers (2014–2014)David A. Sallman · Moffitt Cancer Center1 papers (2025–2025)